Protective effects against simian immunodeficiency virus agm (SIVagm) infection in cynomolgus monkeys immunized with a recombinant vaccinia virus expressing the SIVagm envelope gene

By Ibuki K.   Ido E.   Funahashi S.-i.   Miura T.   Hayami M.   Shida H.  

Vaccine, Vol. 18, Iss. 5, 1999-10 ,pp. : 511-516

Elsevier

Access to resources Recommend Favorite

Immunity to St. Louis encephalitis virus by sequential immunization with recombinant vaccinia and baculovirus derived PrM/E proteins

By Venugopal K.   Jiang W.R.   Gould E.A.  

Vaccine, Vol. 13, Iss. 11, 1995-01 ,pp. : 1000-1005

Elsevier

Access to resources Recommend Favorite

Use of apathogenic vaccinia virus MVA expressing EHV-1 gC as basis of a combined recombinant MVA/DNA vaccination scheme

By Huemer H.P.   Strobl B.   Nowotny N.  

Vaccine, Vol. 18, Iss. 14, 2000-02 ,pp. : 1320-1326

Elsevier

Access to resources Recommend Favorite

Influence of the parental virus strain on the virulence and immunogenicity of recombinant vaccinia viruses expressing HBV preS2-S protein or VZV glycoprotein I

By Kutinova L.   Ludvikova V.   Krystofova J.   Otavova M.   Simonova V.   Nemeckova S.   Hainz P.   Vonka V.  

Vaccine, Vol. 14, Iss. 11, 1996-08 ,pp. : 1045-1052

Elsevier

Access to resources Recommend Favorite

Development and in vitro characterization of recombinant vaccinia viruses expressing bovine leukemia virus gp51 in combination with bovine IL4 or IL12

By Von Beust B.R.   Brown W.C.   Estes D.M.   Zarlenga D.S.   McElwain T.F.   Palmer G.H.  

Vaccine, Vol. 17, Iss. 4, 1999-02 ,pp. : 384-395

Elsevier

Access to resources Recommend Favorite